Inactivated vaccine against dermatomycosis in cattle
Quantitative and qualitative composition of active substances
1 ml of the vaccine contains: Inactivated strain Trichophyton verrucosum 43, minimum concentration 20%
Active immunisation of cattle to reduce mortality rate and clinical symptoms of dermatomycosis induced by Trichophyton verrucosum infection.
Therapeutic use in animals with dermatological symptoms of trichophytosis to accelerate recovery. Immunity occurs 3-4 weeks after the second injection. Immunisation period after two administrations is 9-12 months.
Posology and routes of administration
The vaccine should be administered twice at the interval of 10-14 days.
Administer intramuscularly to the muscle of the pelvic limb according the following scheme:
Prophylaxis from the age of 1 week to 4 months – 5 ml
from the age of 4 to 8 months – 5 ml to 6 ml
over 8 months – 6 ml to 7 ml
Treatment from the age of 1 week to 4 months – 7.5 ml
from the age of 4 to 8 months – 7.5 ml to 9 ml
over 8 months – 9 ml to 10.5 ml
The product can be used in animals during pregnancy or lactation.
Recommendations for proper administration
A slight swelling may occur at the injection site, which remits spontaneously within a few days.
Any adverse reactions emerged after administration of the product or any observed symptoms not listed in the leaflet (including symptoms reported in humans following exposure to the product) should be reported to the competent veterinarian, Marketing Authorization Holder or the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products. The report form should be downloaded from https://www.urpl.gov.pl (Department of Veterinary Medicinal Products).
Special precautions for storage and transport
Keep out of the reach and sight of children.
Store in a refrigerator (2-8°C). Do not freeze.
Once opened, use within 14 days.
Do not use after the expiry date which is stated on the label.
Special warnings and precautions
In case of accidental self-injection, seek medical advice immediately and show the package leaflet or the label to the physician.
There is no available information concerning safety and efficiency of the vaccine used in combination with other medicinal veterinary products. Therefore, the decision to use this vaccine before or after administration of another medicinal veterinary product should be considered individually.
After administration of a double dose, no other adverse reactions occurred than those specified in the section concerning adverse reactions.
Since no conformity studies of this veterinary medicinal product have been conducted, this product must not be combined with other medicinal veterinary products.
Special precautions for the disposal of unused veterinary medicinal product or waste materials derived from the use of such products
Medicines should not be disposed of via wastewater or household waste.
Ask your veterinary surgeon how to dispose of medicines no longer required. These measures should help to protect the environment.
Shelf life 12 months
Available containers 250 ml
For animal treatment only.
Subject to medical prescription – prescription drug.
Marketing autorisation 480/98